InduPro raises $77.0M Series B (United States, Aug 2026)
Reach the investors backing rounds like this
Backed by The Column Group, Vida Ventures +6 more · verified emails and LinkedIn on Datapile
Seattle biotech InduPro raises $77 million to advance cancer treatment pipeline - The Business Journals
InduPro is a biotechnology company focused on defining membrane protein spatial relationships to create novel therapeutics for cancer and autoimmune diseases. The company is advancing its lead oncology program, IDP-001, which is currently in a Phase 1 clinical study targeting advanced squamous non-small cell lung cancer and other solid tumors. This funding round will support the clinical development and proof-of-concept data generation for IDP-001.
Seattle biotech InduPro raises $77 million to advance cancer treatment pipeline The Business Journals
| Sep 23, 2026 | Ema | $77.0M | Series B | United States |
| Sep 23, 2026 | Baselayer | $35.0M | Series A | United States |
| Sep 23, 2026 | Hubble Network | $200.0M | Series C | United States |
| Sep 23, 2026 | Topdog | $2.5M | Seed | United States |
21,380 investors back startups in United States
You just read who funded InduPro. The same database has the investors behind every other round — with verified emails, check sizes and the stages they actually write at.
Free account: 15 investor contact unlocks a month, no card required.